In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Proteus Digital Health, Inc.

http://www.proteus.com/

Latest From Proteus Digital Health, Inc.

BI Finds Right Fit For Digital Therapeutic Partnership With Click

Deal Snapshot: The firms are partnering on a digital therapeutic for schizophrenia in a deal potentially worth $500m. 

Digital Health Deals

Otsuka Rescues Fallen Digital Health Unicorn Proteus

Japanese pharmaceutical company picks up struggling US venture for a fraction of its one-time value as it continues strategic push into the digital health space.

Digital Health M & A

Otsuka Rescues Fallen Unicorn Proteus Digital

Japanese firm picks up struggling US venture for a fraction of its one-time value as it continues strategic push into the digital health space.

Digital Health M & A

GSK Q2 Preview: Focus On PARP And HIV Pill

Analysts are waiting to see how the drugs giant intends to drive growth for new products, with a particular interest in the prospects for the PARP inhibitor Zejula and the single-pill, two-drug HIV therapy Dovato.

Sales & Earnings Cancer
See All

Company Information

  • Industry
  • Digital Health
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Other Names / Subsidiaries
    • Proteus Biomedical Inc.
UsernamePublicRestriction

Register